U.S. Industrials Stock News

TPG Inc. ( NASDAQ:TPG ) shareholders won't be pleased to see that the share price has had a very rough month, dropping...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

Fortune Brands Innovations, Inc. ( NYSE:FBIN ) has announced that it will be increasing its dividend from last year's...

Verizon Communications Inc. ( NYSE:VZ ) shares have had a really impressive month, gaining 26% after a shaky period...

Some Renasant Corporation ( NYSE:RNST ) shareholders may be a little concerned to see that insider Milton Cole recently...

Atara Biotherapeutics, Inc.'s ( NASDAQ:ATRA ) price-to-sales (or "P/S") ratio of 0.2x might make it look like a strong...

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 19x, you may...

Agnico Eagle Mines Limited ( NYSE:AEM ) has announced that it will be increasing its dividend from last year's...

Eversource Energy ( NYSE:ES ) will increase its dividend from last year's comparable payment on the 31st of March to...

The board of Vishay Intertechnology, Inc. ( NYSE:VSH ) has announced that it will pay a dividend on the 26th of March...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 20x, you may...

We wouldn't blame Fifth Third Bancorp ( NASDAQ:FITB ) shareholders if they were a little worried about the fact that...

It's not a stretch to say that Fuel Tech, Inc.'s ( NASDAQ:FTEK ) price-to-sales (or "P/S") ratio of 1.6x right now...

Earlier this week, Barclays upgraded Gossamer Bio to a “Strong Buy” rating, as institutional ownership climbed above 81% and attention centered on its lead investigational drug seralutinib for pulmonary arterial hypertension and related conditions. This combination of a stronger Wall Street stance and concentrated institutional exposure highlights how closely investors are watching seralutinib’s clinical and commercial potential. Against this backdrop, we’ll explore how Barclays’ upgrade and...

If you are wondering whether Array Digital Infrastructure is still fairly priced after its recent run, or if the market is already ahead of itself, this article is for you. The share price recently closed at US$50.88, with returns of 3.9% over 7 days, a 12.0% decline over 30 days, a 5.8% decline year to date, and a 30.1% return over 1 year. Recent news coverage has focused on Array Digital Infrastructure as part of broader discussions about digital infrastructure and telecom related stocks,...

Revolve Group (NYSE:RVLV) has opened a flagship store at The Grove in Los Angeles. The new location brings the REVOLVE and FWRD brands into a single, high profile physical space. This marks an expansion of the company’s offline footprint beyond its core online model. Revolve Group is stepping further into brick and mortar with a flagship store at The Grove, a move that puts its online native brands in front of heavy foot traffic. The stock closed at $25.09, with returns over the past year...

If you are wondering whether Upbound Group’s current share price still offers value, this article will walk through the numbers in a clear, practical way. The stock last closed at US$20.31, with a 17.1% gain year to date, following a 26.0% decline over the past year and a 50.2% decline over five years. Recent headlines around Upbound Group have focused on its position in the US retail space and how its business model fits within broader consumer spending trends. This backdrop helps explain...

Wendy's (WEN) closed FY 2025 with Q4 revenue of US$543 million and basic EPS of US$0.14, supported by trailing twelve month revenue of about US$2.2 billion and EPS of US$0.85 that frame the latest quarter in a softer earnings backdrop. Over recent periods, revenue has moved from US$574 million and EPS of US$0.23 in Q4 2024 to US$543 million and EPS of US$0.14 in Q4 2025. Trailing twelve month EPS shifted from US$0.95 at Q4 2024 to US$0.85 at Q4 2025, setting a more cautious tone around...

Pulmovant, a Roivant Sciences company, has completed patient enrollment in the Phase 2 PHocus trial of mosliciguat for pulmonary hypertension associated with interstitial lung disease. Enrollment finished ahead of schedule, marking a key clinical milestone for this potential first in class inhaled therapy. For investors watching Roivant Sciences (NasdaqGS:ROIV), this clinical update adds fresh context to a stock that has seen a very large 1 year return and a 20.6% gain year to date. Shares...

North of South Capital reduced its stake in Vipshop Holdings in the fourth quarter. The move affects institutional ownership of Vipshop Holdings, ticker NYSE:VIPS. Vipshop continues to report profitability and run share buybacks despite the position cut. For you as a shareholder or watcher of NYSE:VIPS, this shift in ownership comes with a mixed backdrop. The stock closed at $17.54, with a 1 year return of 18.2% and a 3 year return of 35.3%. The 5 year return shows a 48.6% decline. Short...

LuxExperience B.V (LUXE) is back in focus after a cluster of analyst upgrades and fresh coverage, supported by robust reported sales, improving profitability in core brands, and ongoing progress on its multi year transformation plan. See our latest analysis for LuxExperience B.V. The 7 day share price return of 41.45% and 30 day share price return of 29.43% suggest strong short term momentum, even though the 1 year total shareholder return is a 5.32% loss and the 5 year total shareholder...

Dutch Bros (BROS) just wrapped up FY 2025 with fourth quarter revenue of US$443.6 million and basic EPS of US$0.17, capping a twelve month run that produced total revenue of about US$1.6 billion and EPS of roughly US$0.64. Over the past six quarters, the company has seen quarterly revenue move from US$338.2 million to US$443.6 million while basic EPS shifted from US$0.11 in Q3 2024 to a range of US$0.13 to US$0.20 across 2025. This sets up a story where higher net income and a trailing net...

International Flavors & Fragrances (NYSE:IFF) has started a formal sale process for its Food Ingredients business. The move is part of a broader effort to reshape the portfolio through multiple divestitures and focus on higher value segments. Management is targeting improved capital allocation and an emphasis on businesses it sees as core to long term value creation. IFF enters this phase of portfolio reshaping with its shares at $83.0 and a mixed return profile. The stock is up 10.9% over...